Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 166

1.

The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.

Kahn SE.

Diabetologia. 2003 Jan;46(1):3-19. Epub 2003 Jan 11. Review.

PMID:
12637977
[PubMed - indexed for MEDLINE]
2.

Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity.

Kahn SE, Prigeon RL, Schwartz RS, Fujimoto WY, Knopp RH, Brunzell JD, Porte D Jr.

J Nutr. 2001 Feb;131(2):354S-60S. Review.

PMID:
11160560
[PubMed - indexed for MEDLINE]
Free Article
3.

The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus.

Kahn SE.

Am J Med. 2000 Apr 17;108 Suppl 6a:2S-8S. Review.

PMID:
10764844
[PubMed - indexed for MEDLINE]
4.

Prevention of type 2 diabetes: insulin resistance and beta-cell function.

Chiasson JL, Rabasa-Lhoret R.

Diabetes. 2004 Dec;53 Suppl 3:S34-8. Review.

PMID:
15561919
[PubMed - indexed for MEDLINE]
Free Article
5.

Is insulin resistance the principal cause of type 2 diabetes?

Gerich JE.

Diabetes Obes Metab. 1999 Sep;1(5):257-63. Review.

PMID:
11225637
[PubMed - indexed for MEDLINE]
6.

Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.

Festa A, Williams K, Hanley AJ, Haffner SM.

Diabetes. 2008 Jun;57(6):1638-44. doi: 10.2337/db07-0954. Epub 2008 Mar 10.

PMID:
18332099
[PubMed - indexed for MEDLINE]
Free Article
7.

Beta cell failure: causes and consequences.

Kahn SE.

Int J Clin Pract Suppl. 2001 Sep;(123):13-8. Review.

PMID:
11594291
[PubMed - indexed for MEDLINE]
8.

Beta-cell function and mass in type 2 diabetes.

Larsen MO.

Dan Med Bull. 2009 Aug;56(3):153-64.

PMID:
19728971
[PubMed - indexed for MEDLINE]
9.

The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes.

Bergman RN, Finegood DT, Kahn SE.

Eur J Clin Invest. 2002 Jun;32 Suppl 3:35-45. Review.

PMID:
12028373
[PubMed - indexed for MEDLINE]
10.

Clinical features of insulin resistance and beta cell dysfunction and the relationship to type 2 diabetes.

Stumvoll M, Gerich J.

Clin Lab Med. 2001 Mar;21(1):31-51. Review.

PMID:
11321936
[PubMed - indexed for MEDLINE]
11.

[Insulin sensitivity and beta function in the first-degree relatives of type 2 diabetic patients].

Han XY, Ji LN, Zhou XH.

Zhonghua Yi Xue Za Zhi. 2004 Nov 2;84(21):1777-80. Chinese.

PMID:
15631772
[PubMed - indexed for MEDLINE]
12.

Determinants of estimated insulin resistance and beta-cell function in Indian, Creole and Chinese Mauritians. The Mauritius NCD Study Group.

Dowse GK, Qin H, Collins VR, Zimmet PZ, Alberti KG, Gareeboo H.

Diabetes Res Clin Pract. 1990 Nov-Dec;10(3):265-79.

PMID:
2073874
[PubMed - indexed for MEDLINE]
13.

Pancreatic beta-cell function and insulin sensitivity in japanese subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes mellitus.

Kanauchi M, Nakajima M, Saito Y, Kanauchi K.

Metabolism. 2003 Apr;52(4):476-81.

PMID:
12701062
[PubMed - indexed for MEDLINE]
14.

Mechanisms linking obesity to insulin resistance and type 2 diabetes.

Kahn SE, Hull RL, Utzschneider KM.

Nature. 2006 Dec 14;444(7121):840-6. Review.

PMID:
17167471
[PubMed - indexed for MEDLINE]
15.

Beta cell function, insulin resistance and plasma adiponectin concentrations are predictors for the change of postprandial glucose in non-diabetic subjects at risk for type 2 diabetes.

Thamer C, Haap M, Heller E, Joel L, Braun S, Tschritter O, Haring H, Fritsche A.

Horm Metab Res. 2006 Mar;38(3):178-82.

PMID:
16673209
[PubMed - indexed for MEDLINE]
16.

Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications.

Retnakaran R, Hanley AJ, Raif N, Hirning CR, Connelly PW, Sermer M, Kahn SE, Zinman B.

Diabetologia. 2005 May;48(5):993-1001. Epub 2005 Mar 19.

PMID:
15778860
[PubMed - indexed for MEDLINE]
17.

[And what about diabetes?].

Cerasi E.

Bull Acad Natl Med. 2007 Apr-May;191(4-5):941-3; discussion 943. French.

PMID:
18225448
[PubMed - indexed for MEDLINE]
18.

Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes.

Cnop M, Vidal J, Hull RL, Utzschneider KM, Carr DB, Schraw T, Scherer PE, Boyko EJ, Fujimoto WY, Kahn SE.

Diabetes Care. 2007 Mar;30(3):677-82.

PMID:
17327340
[PubMed - indexed for MEDLINE]
19.

Potential role of oral thiazolidinedione therapy in preserving beta-cell function in type 2 diabetes mellitus.

Walter H, L├╝bben G.

Drugs. 2005;65(1):1-13. Review.

PMID:
15610048
[PubMed - indexed for MEDLINE]
20.

Lack of association of liver fat with model parameters of beta-cell function in men with impaired glucose tolerance and type 2 diabetes.

Tushuizen ME, Bunck MC, Pouwels PJ, Bontemps S, Mari A, Diamant M.

Eur J Endocrinol. 2008 Sep;159(3):251-7. doi: 10.1530/EJE-08-0424. Epub 2008 Jun 26.

PMID:
18583389
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk